The table below shows Ensysce Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$5.07M
$5.21M
$2.23M
$2.52M
$3.53M
$3.93M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$10.38M
$7.22M
$7.59M
$19.84M
$4.69M
$4.39M
SG&A
$4.93M
ENSC annual revenue (10-K history)
Ensysce Biosciences, Inc. reported annual revenue of $5.07M for fiscal year 2025. That is down 2.8% from $5.21M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $3.93M (FY 2020) to $5.07M. Figures come from the company's audited annual reports as filed with the SEC.